Home NDC 50090-1392 MARLISSA
Product NDC 50090-1392
11-digit product format 500901392
Labeler code 50090
Product ID 50090-1392_4fa0bd26-093d-46be-af5b-2d0ba528a36f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Levonorgestrel and Ethinyl Estradiol
Dosage form KIT
Labeler A-S Medication Solutions
Application ANDA091452
Marketing category ANDA
Marketing start 2012-02-29
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50090-1392-0 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50090-1392-0 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50090-1392-0 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50090-1392-0 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50090-1392-0 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50090-1392-0 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50090-1392-0 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50090-1392-0 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50090-1392-0 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 50090-1392-0 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 50090-1392-0 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 50090-1392-0 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091452-001 MARLISSA ETHINYL ESTRADIOL; LEVONORGESTREL 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A091452-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A091452-001 MARLISSA 0.03MG;0.15MG TABLET / ORAL-28 AB 2012-02-29 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join MARLISSA LEVONORGESTREL AND ETHINYL ESTRADIOL Glenmark Pharmaceuticals Inc., USA 9379d99e-c416-4dab-a817-1c110e0d4b93 2026-01-29 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091452 application number: ANDA091452
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-1392-0 50090139200 1 KIT in 1 KIT (50090-1392-0) 1 kit 2014-11-28 0000-00-00 No No Current